title: Run batch effects potentially compromise the usefulness of genomic signatures for ovarian cancer.
authors.forename: Keith A
authors.initials: KA
authors.lastname: Baggerly
authors.forename: Kevin R
authors.initials: KR
authors.lastname: Coombes
authors.forename: E Shannon
authors.initials: ES
authors.lastname: Neeley
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D023281:Genomics; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000235:genetics*; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents